Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Dose-Finding Trial of Letrozole in Postmenopausal Women at High Risk for Breast Cancer

NCT01077453 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT01077453
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01077453 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Dose-Finding Trial of Letrozole in Postmenopausal Women at High Risk for Breast Cancer
Lead sponsor
National Cancer Institute (NCI)
Phase
Phase 1
Overall status
Completed
Start date
March 31, 2010
Completion date
Not reported
Enrollment
112 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

healthy, no evidence of disease, lobular breast carcinoma in situ